Longwood Capital Partners as of March 31, 2015
Portfolio Holdings for Longwood Capital Partners
Longwood Capital Partners holds 51 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amicus Therapeutics (FOLD) | 18.0 | $21M | 2.0M | 10.88 | |
| Lion Biotechnologies | 6.8 | $8.1M | 669k | 12.11 | |
| Cempra | 4.9 | $5.8M | 170k | 34.31 | |
| Alimera Sciences | 4.5 | $5.3M | 1.1M | 5.01 | |
| Biotelemetry | 3.6 | $4.3M | 481k | 8.85 | |
| Exelixis Note 4.25% 8/1 (Principal) | 3.5 | $4.2M | 5.5M | 0.76 | |
| Ascendis Pharma A S Spons Adr (ASND) | 3.3 | $4.0M | 229k | 17.35 | |
| Zafgen | 3.3 | $4.0M | 100k | 39.61 | |
| LeMaitre Vascular (LMAT) | 3.3 | $3.9M | 466k | 8.38 | |
| Pernix Therapeutics Holdings | 3.2 | $3.7M | 350k | 10.69 | |
| Oxford Immunotec Global Ord Shs | 2.6 | $3.1M | 222k | 14.08 | |
| Insmed Com Par $.01 (INSM) | 2.6 | $3.1M | 150k | 20.80 | |
| Rr Media SHS | 2.6 | $3.1M | 405k | 7.66 | |
| Build-A-Bear Workshop (BBW) | 2.5 | $2.9M | 150k | 19.65 | |
| Cas Med Sys Com Par $0.004 | 2.4 | $2.9M | 2.2M | 1.34 | |
| IRIDEX Corporation (IRIX) | 2.1 | $2.5M | 236k | 10.68 | |
| Ishares Tr Russell 2000 Etf Put Option (IWM) | 2.1 | $2.5M | 20k | 124.35 | |
| Cardiome Pharma Com No Par | 1.9 | $2.2M | 238k | 9.26 | |
| Orthofix International Nv Com Stk | 1.8 | $2.2M | 60k | 35.88 | |
| Insulet Corporation (PODD) | 1.7 | $2.1M | 62k | 33.36 | |
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 1.7 | $2.1M | 10k | 206.40 | |
| Aurinia Pharmaceuticals (AUPH) | 1.6 | $1.9M | 430k | 4.36 | |
| Flex Pharma | 1.5 | $1.8M | 90k | 19.60 | |
| Combimatrix Corporation | 1.4 | $1.7M | 880k | 1.90 | |
| Avid Technology | 1.3 | $1.5M | 101k | 14.90 | |
| Neuroderm Ord Shs | 1.2 | $1.4M | 103k | 13.42 | |
| Innocoll Spons Adr | 1.1 | $1.3M | 165k | 7.95 | |
| Histogenics Corp Cmn | 1.0 | $1.2M | 123k | 9.99 | |
| Cardica | 1.0 | $1.1M | 1.8M | 0.63 | |
| Bellicum Pharma | 0.9 | $1.0M | 44k | 23.17 | |
| Nic | 0.9 | $1.0M | 57k | 17.68 | |
| Ignyta | 0.8 | $995k | 100k | 9.95 | |
| NxStage Medical | 0.8 | $928k | 54k | 17.29 | |
| Sorrento Therapeutics Call Option (SRNEQ) | 0.8 | $925k | 80k | 11.56 | |
| AVEO Pharmaceuticals | 0.7 | $861k | 594k | 1.45 | |
| Exelixis Call Option (EXEL) | 0.7 | $846k | 329k | 2.57 | |
| Dyax Call Option | 0.7 | $838k | 50k | 16.76 | |
| Agile Therapeutics | 0.6 | $750k | 81k | 9.26 | |
| Otonomy | 0.6 | $707k | 20k | 35.35 | |
| Chembio Diagnostics | 0.5 | $590k | 146k | 4.04 | |
| Mol Global Spons Adr | 0.5 | $563k | 246k | 2.29 | |
| Kindred Biosciences | 0.5 | $536k | 75k | 7.15 | |
| Discovery Laboratories | 0.4 | $468k | 393k | 1.19 | |
| Genvec | 0.4 | $456k | 155k | 2.95 | |
| Cerus Corporation (CERS) | 0.4 | $417k | 100k | 4.17 | |
| Semler Scientific (SMLR) | 0.3 | $403k | 115k | 3.50 | |
| Sage Therapeutics (SAGE) | 0.3 | $402k | 8.0k | 50.25 | |
| Marinus Pharmaceuticals | 0.3 | $325k | 36k | 9.00 | |
| Zosano Pharma | 0.2 | $222k | 22k | 10.11 | |
| AngioDynamics (ANGO) | 0.1 | $178k | 10k | 17.80 | |
| Therapeuticsmd | 0.1 | $114k | 19k | 6.03 |
